Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Clinical Significance
100%
EGFR mutation
100%
Mutation Type
100%
Lung Adenocarcinoma
100%
Korean Studies
100%
Epidermal Growth Factor Receptor Inhibitors (EGFRI)
100%
Advanced Lung Adenocarcinoma
33%
Exon
16%
Genetic Modification
16%
Point mutation
16%
Prognostic Factors
16%
Non-small Cell Lung Cancer (NSCLC)
16%
Non-responders
16%
Positive Groups
16%
Adenocarcinoma
16%
Mutant Epidermal Growth Factor Receptor
16%
Tyrosine Kinase Inhibitor
16%
Favorable Prognosis
16%
Increased Mortality
16%
Most Common Form
16%
Better Prognosis
16%
Mutation Sites
16%
Exon 19
16%
Good Prognosis
16%
Specific mutation
16%
L858R mutation
16%
Mutation Data
16%
Differential Survival
16%
Medical Institutes
16%
TKI Treatment
16%
Uncommon mutation
16%
Medicine and Dentistry
Clinical Significance
100%
Epidermal Growth Factor Receptor
100%
Lung Adenocarcinoma
100%
Exon
15%
Non Small Cell Lung Cancer
7%
Adenocarcinoma
7%
Prognostic Factor
7%
Tyrosine-Kinase Inhibitor
7%
Point Mutation
7%
Genetics
7%
Neuroscience
Epidermal Growth Factor Receptor
100%
Lung Adenocarcinoma
100%
Exon
15%
Point Mutation
7%
Tyrosine Kinase Inhibitor
7%
Genetics
7%
Pharmacology, Toxicology and Pharmaceutical Science
Epidermal Growth Factor Receptor
100%
Lung Adenocarcinoma
100%
Non Small Cell Lung Cancer
7%
Adenocarcinoma
7%
Protein Tyrosine Kinase Inhibitor
7%